Jennifer L Lund (Jennifer Lund)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 66

Top Topics

Advanced Cancer

Metastatic Renal Cell Carcinoma

Community Dwelling

Clinical Practice

Top Venues

Pharmacoepidemiology and drug safety

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Charles E Gaber, Abdullah I Abdelaziz, Jyotirmoy Sarker, Jennifer L Lund, Evan S Dellon, Cary C Cotton, Swathi Eluri, Nicholas J Shaheen
Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus. Pharmacoepidemiology and drug safety 33 (2) (2024)
Emilie D Duchesneau, Dae Hyun Kim, Til Stürmer, Katherine Reeder-Hayes, Jessie K Edwards, Keturah R Faurot, Jennifer L Lund
Longitudinal changes in a claims-based frailty proxy measure compared to concurrent changes in the Fried frailty phenotype. The journals of gerontology. Series A, Biological sciences and medical sciences (2024)
Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Joshua D Niznik, Shahar Shmuel, Virginia Pate, Carolyn T Thorpe, Laura C Hanson, Colleen Rice, Jennifer L Lund
Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative data. Pharmacoepidemiology and drug safety 33 (4) (2024)
Jennifer L Lund, M Patricia Rivera, I-Hsuan Su, Jason M Long, Xiaomeng Chen Msph, Joyce Pak, Michael G Hudgens, Til Stürmer, Daniel S Reuland, Louise M Henderson
Estimating the effects of cancer screening in clinical practice settings: The role of selective uptake and suboptimal adherence along the cancer screening continuum. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Jennifer L Lund, M Patricia Rivera, I-Hsuan Su, Jason M Long, Xiaomeng Chen Msph, Joyce Pak, Michael G Hudgens, Til Stürmer, Daniel S Reuland, Louise M Henderson
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Joshua D Niznik, Shahar Shmuel, Virginia Pate, Carolyn T Thorpe, Laura C Hanson, Colleen Rice, Jennifer L Lund
Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative data. Pharmacoepidemiology and drug safety 33 (4) (2024)
Emilie D Duchesneau, Dae Hyun Kim, Til Stürmer, Katherine Reeder-Hayes, Jessie K Edwards, Keturah R Faurot, Jennifer L Lund
Longitudinal Changes in a Claims-Based Frailty Proxy Measure Compared to Concurrent Changes in the Fried Frailty Phenotype. The journals of gerontology. Series A, Biological sciences and medical sciences 79 (9) (2024)
Charles E Gaber, Abdullah I Abdelaziz, Jyotirmoy Sarker, Jennifer L Lund, Evan S Dellon, Cary C Cotton, Swathi Eluri, Nicholas J Shaheen
Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus. Pharmacoepidemiology and drug safety 33 (2) (2024)
Emilie D Duchesneau, Dae Hyun Kim, Til Stürmer, Katherine Reeder-Hayes, Jessie K Edwards, Keturah R Faurot, Jennifer L Lund
Longitudinal Changes in a Claims-Based Frailty Proxy Measure Compared to Concurrent Changes in the Fried Frailty Phenotype. The journals of gerontology. Series A, Biological sciences and medical sciences 79 (9) (2024)
Joshua D Niznik, Shahar Shmuel, Virginia Pate, Carolyn T Thorpe, Laura C Hanson, Colleen Rice, Jennifer L Lund
Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative data. Pharmacoepidemiology and drug safety 33 (4) (2024)
Jennifer L Lund, M Patricia Rivera, I-Hsuan Su, Jason M Long, Xiaomeng Chen Msph, Joyce Pak, Michael G Hudgens, Til Stürmer, Daniel S Reuland, Louise M Henderson
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Christopher Edward Jensen, Tzy-Mey Kuo, Matthew R Leblanc, Christopher D Baggett, Emilie D Duchesneau, Xi Zhou, Katherine E Reeder-Hayes, Jennifer L Lund
Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple Myeloma. JCO clinical cancer informatics 8 (2024)
Emilie D Duchesneau, Dae Hyun Kim, Til Stürmer, Katherine Reeder-Hayes, Jessie K Edwards, Keturah R Faurot, Jennifer L Lund
Longitudinal changes in a claims-based frailty proxy measure compared to concurrent changes in the Fried frailty phenotype. The journals of gerontology. Series A, Biological sciences and medical sciences (2024)
Jennifer L Lund, M Patricia Rivera, I-Hsuan Su, Jason M Long, Xiaomeng Chen Msph, Joyce Pak, Michael G Hudgens, Til Stürmer, Daniel S Reuland, Louise M Henderson
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Joshua D Niznik, Shahar Shmuel, Virginia Pate, Carolyn T Thorpe, Laura C Hanson, Colleen Rice, Jennifer L Lund
Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative data. Pharmacoepidemiology and drug safety 33 (4) (2024)
Christopher Edward Jensen, Tzy-Mey Kuo, Matthew R Leblanc, Christopher D Baggett, Emilie D Duchesneau, Xi Zhou, Katherine E Reeder-Hayes, Jennifer L Lund
Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple Myeloma. JCO clinical cancer informatics 8 (2024)
Chase D Latour, I-Hsuan Su, Megan Delgado, Virginia Pate, Charles Poole, Jessie K Edwards, Til Stürmer, Jennifer L Lund, Michele Jonsson Funk
Hazard Ratios and Alternative Effect Measures: An Applied Illustration. Pharmacoepidemiology and drug safety 33 (9) (2024)
Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Jennifer L Lund, M Patricia Rivera, I-Hsuan Su, Jason M Long, Xiaomeng Chen Msph, Joyce Pak, Michael G Hudgens, Til Stürmer, Daniel S Reuland, Louise M Henderson
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Chase D Latour, Megan Delgado, I-Hsuan Su, Catherine Wiener, Clement O Acheampong, Charles Poole, Jessie K Edwards, Kenneth Quinto, Til Stürmer, Jennifer L Lund, Jie Li, Nahleen Lopez, John Concato, Michele Jonsson Funk
Use of Sensitivity Analyses to Assess Uncontrolled Confounding from Unmeasured Variables in Observational, Active Comparator Pharmacoepidemiologic Studies: A Systematic Review. American journal of epidemiology (2024)
Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Christopher Edward Jensen, Tzy-Mey Kuo, Matthew R Leblanc, Christopher D Baggett, Emilie D Duchesneau, Xi Zhou, Katherine E Reeder-Hayes, Jennifer L Lund
Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple Myeloma. JCO clinical cancer informatics 8 (2024)
Jennifer L Lund, Jenna Cacciatore, Rachael G Tylock, I-Hsuan Su, Saloni Sharma, Sharon Peacock Hinton, Sabirah Smith, Molly A Nowels, Xiaomeng Chen Msph, Paul R Duberstein, Laura C Hanson, Supriya G Mohile
Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO clinical cancer informatics 8 (2024)
Emilie D Duchesneau, Dae Hyun Kim, Til Stürmer, Katherine Reeder-Hayes, Jessie K Edwards, Keturah R Faurot, Jennifer L Lund
Longitudinal Changes in a Claims-Based Frailty Proxy Measure Compared to Concurrent Changes in the Fried Frailty Phenotype. The journals of gerontology. Series A, Biological sciences and medical sciences 79 (9) (2024)
Christine D Hsu, Louise M Henderson, Bradford E Jackson, Christopher D Baggett, Michele Jonsson Funk, Andrew F Olshan, Parul Gupta, Alfred Sidney Barritt, Hanna K Sanoff, Stephanie B Wheeler, Andrew M Moon, Jennifer L Lund
Hepatocellular Carcinoma Surveillance Among Individuals with Cirrhosis: Trends by Payer, Etiology and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Sejin Lee, Antonia V Bennett, Xi Zhou, Allison Betof Warner, Justin G Trogdon, Erin E Kent, Jennifer L Lund
Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy. Pharmacoepidemiology and drug safety (2023)
Jennifer L Lund, Vincent Lo Re
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here? Pharmacoepidemiology and drug safety (2023)
Sejin Lee, Antonia V Bennett, Xi Zhou, Allison Betof Warner, Justin G Trogdon, Erin E Kent, Jennifer L Lund
Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy. Pharmacoepidemiology and drug safety (2023)
Jennifer L Lund, Michael A Webster-Clark, Daniel Westreich, Hanna K Sanoff, Nicholas Robert, Jennifer R Frytak, Marley Boyd, Shahar Shmuel, Til Stürmer, Alexander P Keil
Visualizing External Validity: Graphical Displays to Inform the Extension of Treatment Effects from Trials to Clinical Practice. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Sejin Lee, Antonia V Bennett, Xi Zhou, Allison Betof Warner, Justin G Trogdon, Erin E Kent, Jennifer L Lund
Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy. Pharmacoepidemiology and drug safety (2023)
Allison Musty, Jennifer L Lund, Yang Claire Yang, Joshua D Niznik, Shahar Shmuel, Emilie D Duchesneau
The association between wealth and sleep medication use in a nationally-representative sample of older Medicare beneficiaries. Pharmacoepidemiology and drug safety (2023)
Jennifer L Lund, Michael A Webster-Clark, Daniel Westreich, Hanna K Sanoff, Nicholas Robert, Jennifer R Frytak, Marley Boyd, Shahar Shmuel, Til Stürmer, Alexander P Keil
Visualizing External Validity: Graphical Displays to Inform the Extension of Treatment Effects from Trials to Clinical Practice. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Christine D Hsu, Louise M Henderson, Bradford E Jackson, Christopher D Baggett, Michele Jonsson Funk, Andrew F Olshan, Parul Gupta, Alfred Sidney Barritt, Hanna K Sanoff, Stephanie B Wheeler, Andrew M Moon, Jennifer L Lund
Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Emilie D Duchesneau, Shahar Shmuel, Keturah R Faurot, Allison Musty, Jihye Park, Til Stürmer, Alan C Kinlaw, Yang Claire Yang, Jennifer L Lund
Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends Study. PloS one 18 (6) (2023)
Jennifer L Lund, Michael A Webster-Clark, Daniel Westreich, Hanna K Sanoff, Nicholas Robert, Jennifer R Frytak, Marley Boyd, Shahar Shmuel, Til Stürmer, Alexander P Keil
Visualizing External Validity: Graphical Displays to Inform the Extension of Treatment Effects from Trials to Clinical Practice. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Joyce Pak, Jennifer L Lund, Alexander Keil, Daniel Westreich, Til Stürmer, David Wohl, Claire Farel, M Bradley Drummond, Michael Webster-Clark
A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics. Pharmacoepidemiology and drug safety 31 (12) (2022)
Jessica Chubak, Jennifer L Lund
Noncancer comparators in cancer survivorship studies. Cancer 128 (15) (2022)
Monica E D'Arcy, Til Stürmer, Robert S Sandler, John A Baron, Michele L Jonsson-Funk, Melissa A Troester, Jennifer L Lund
Healthcare system engagement and algorithm-identified cancer incidence following initiation of a new medication. Pharmacoepidemiology and drug safety (2022)
Danielle S Chun, Blánaid M Hicks, Sharon Peacock Hinton, Michele Jonsson Funk, Kyna Gooden, Alexander P Keil, Hung-Jui Tan, Til Stürmer, Jennifer L Lund
Comparison of Approaches for Measuring Adherence and Persistence to Oral Oncologic Therapies in Patients Diagnosed with Metastatic Renal Cell Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (4) (2022)
Chelsea Anderson, Andrew F Olshan, Jihye Park, Victoria L Bae-Jump, Wendy R Brewster, Jennifer L Lund, Hazel B Nichols
Adverse Urinary System Diagnoses among Older Women with Endometrial Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (7) (2022)
Emilie D Duchesneau, Bradford E Jackson, Michael A Webster-Clark, Jennifer L Lund, Katherine E Reeder-Hayes, Anna Maria Napoles, Paula D Strassle
The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (11) (2022)
Emilie D Duchesneau, Alan C Kinlaw, Michele Jonsson Funk, Virginia Pate, Jennifer L Lund
Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States from 2010 to 2019. Pharmacoepidemiology and drug safety 31 (4) (2022)
Shahar Shmuel, Virginia Pate, Marc J Pepin, Janine C Bailey, Yvonne M Golightly, Laura C Hanson, Til Stürmer, Rebecca B Naumann, Danijela Gnjidic, Jennifer L Lund
Effects of anticholinergic and sedative medication use on fractures: A self-controlled design study. Journal of the American Geriatrics Society 69 (11) (2021)
Katherine E Reeder-Hayes, Sophie E Mayer, Jennifer L Lund
Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer. Cancer 127 (8) (2021)
Ronac Mamtani, Jennifer L Lund, Rebecca A Hubbard
'Considering the totality of evidence: Combining real-world data with clinical trial results to better inform decision-making. Pharmacoepidemiology and drug safety 30 (6) (2021)
Danielle R Gartner, Paul L Delamater, Robert A Hummer, Jennifer L Lund, Brian W Pence, Whitney R Robinson
Patterns of black and white hysterectomy incidence among reproductive aged women. Health services research 56 (5) (2021)
Shahar Shmuel, Jeff Yufeng Yang, Sydney Thai, Michael Webster-Clark, Jennifer L Lund
Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer. Cancer 127 (4) (2020)
Michael A Webster-Clark, Til Stürmer, Jessie K Edwards, Charles Poole, Ross J Simpson, Jennifer L Lund
Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults. Pharmacoepidemiology and drug safety 29 (8) (2020)
Jennifer L Lund, Michael A Webster-Clark, Sharon Peacock Hinton, Shahar Shmuel, Til Stürmer, Hanna K Sanoff
Effectiveness of adjuvant FOLFOX vs 5FU/LV in adults over age 65 with stage II and III colon cancer using a novel hybrid approach. Pharmacoepidemiology and drug safety 29 (12) (2020)
Shahar Shmuel, Virginia Pate, Marc J Pepin, Janine C Bailey, Laura C Hanson, Til Stürmer, Rebecca B Naumann, Yvonne M Golightly, Danijela Gnjidic, Jennifer L Lund
Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries. Pharmacoepidemiology and drug safety 30 (2) (2020)
Donna R Rivera, Mugdha N Gokhale, Matthew W Reynolds, Elizabeth B Andrews, Danielle S Chun, Kevin Haynes, Michele L Jonsson-Funk, Kristine E Lynch, Jennifer L Lund, Helen Strongman, Harshvinder Bhullar, Sudha R Raman
Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiology and drug safety 29 (1) (2020)
Elizabeth A Suarez, Kim Boggess, Stephanie M Engel, Til Stürmer, Jennifer L Lund, Michele Jonsson Funk
Ondansetron use in early pregnancy and the risk of late pregnancy outcomes. Pharmacoepidemiology and drug safety 30 (2) (2020)
Elizabeth A Suarez, Kim Boggess, Stephanie M Engel, Til Stürmer, Jennifer L Lund, Michele Jonsson Funk
Ondansetron use in early pregnancy and the risk of miscarriage. Pharmacoepidemiology and drug safety 30 (2) (2020)
Joseph C Engeda, Stefan K Lhachimi, Wayne D Rosamond, Jennifer L Lund, Thomas C Keyserling, Monika M Safford, Lisandro D Colantonio, Paul Muntner, Christy L Avery
Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study. PLoS medicine 17 (8) (2020)
Lisa P Spees, Stephanie B Wheeler, Xi Zhou, Krutika B Amin, Christopher D Baggett, Jennifer L Lund, Benjamin Y Urick, Joel F Farley, Katherine E Reeder-Hayes, Justin G Trogdon
Changes in chronic medication adherence, costs, and health care use after a cancer diagnosis among low-income patients and the role of patient-centered medical homes. Cancer 126 (21) (2020)
Jennifer L Lund, Tzy-Mey Kuo, M Alan Brookhart, Anne-Marie Meyer, Alexandra F Dalton, Christine E Kistler, Stephanie B Wheeler, Carmen L Lewis
Development and validation of a 5-year mortality prediction model using regularized regression and Medicare data. Pharmacoepidemiology and drug safety 28 (5) (2019)
Chelsea Anderson, Jennifer L Lund, Mark A Weaver, William A Wood, Andrew F Olshan, Hazel B Nichols
Noncancer mortality among adolescents and young adults with cancer. Cancer 125 (12) (2019)
Christine D Hsu, Sharon Peacock Hinton, Katherine E Reeder-Hayes, Hanna K Sanoff, Jennifer L Lund
Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with Cyclophosphamide. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (2) (2019)
Danielle S Chun, Jennifer L Lund, Til Stürmer
Pharmacoepidemiology and Drug Safety's special issue on validation studies. Pharmacoepidemiology and drug safety 28 (2) (2019)
Nicole L Pratt, Christina D Mack, Anne Marie Meyer, Kourtney J Davis, Bradley G Hammill, Christian Hampp, Soko Setoguchi, Sudha R Raman, Danielle S Chun, Til Stürmer, Jennifer L Lund
Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting. Pharmacoepidemiology and drug safety 29 (1) (2019)
Chelsea Anderson, Jennifer L Lund, Mark A Weaver, William A Wood, Andrew F Olshan, Hazel B Nichols
Disparities in Mortality from Noncancer Causes among Adolescents and Young Adults with Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (9) (2019)
Jessica C Young, Jennifer L Lund, Nabarun Dasgupta, Michele Jonsson Funk
Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids. Pharmacoepidemiology and drug safety 28 (1) (2018)